Loading live market data…

Rhythm Pharmaceuticals, Inc.

NASDAQ:RYTM

$109.69 USD

-$0.27 (-0.25%)

Volume
397.8K
Average Volume
808.67K
Market Capitalization
$7.52B
P/E Ratio
-35.04
Dividend Yield
0.00%
Price Target
$141.00
Year High
$122.20
Year Low
$74.50
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$4.17

RYTM Estimated and Actual Revenue by Quarter

RYTM Estimated and Actual EPS by Quarter

RYTM Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2027-12-31 4 -182.79M -161.23M -172.73M -183.05M -161.47M -172.98M
2027-09-30 5 -155.55M -137.2M -146.99M -155.77M -137.4M -147.2M
2027-06-30 4 -132.34M -116.73M -125.05M -132.53M -116.9M -125.23M
2027-03-31 4 -105M -92.62M -99.22M -105.15M -92.75M -99.36M
2026-12-31 8 -97.38M -85.9M -92.02M -97.52M -86.02M -92.15M
2026-09-30 9 -81.61M -69.95M -77.76M -81.73M -70.06M -77.87M
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2027-12-31 4 14.28M 16.82M 15.63M 959.41M 1.09B 1.03B
2027-09-30 5 -3.11M -2.64M -2.89M 816.42M 925.57M 874.63M
2027-06-30 4 -24.31M -20.65M -22.6M 694.6M 787.46M 744.12M
2027-03-31 4 -48.38M -41.08M -44.97M 551.12M 624.8M 590.41M
2026-12-31 8 -52.94M -44.96M -49.22M 511.13M 579.46M 547.57M
2026-09-30 9 -55.14M -50.84M -52.99M 416.26M 485.63M 462.71M
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2027-12-31 4 163.94M 185.85M 175.62M 2 0.2101 0.24741 0.23
2027-09-30 5 139.5M 158.15M 149.45M 2 -0.04571776 -0.03882282 -0.0425
2027-06-30 4 118.69M 134.56M 127.15M 2 -0.35767 -0.30373 -0.3325
2027-03-31 4 94.17M 106.76M 100.89M 3 -0.71169 -0.60436 -0.6616
2026-12-31 8 87.34M 99.01M 93.56M 3 -0.77888 -0.66141 -0.72406
2026-09-30 9 71.13M 82.98M 79.06M 7 -0.81119 -0.74798 -0.77959